SMTL ID : 7jn5.1

Crystal structure of SARS-CoV receptor binding domain in complex with human antibody CR3022

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.71 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 3 residues within 4Å: Chain A: Y.27 Chain C: S.48, N.52 No protein-ligand interaction detected (PLIP)

1 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.2: 8 residues within 4Å: Chain A: L.146, V.174, S.182, L.183, S.184 Chain B: Q.166, S.182, T.184 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:S.182, B:T.184

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.3: 4 residues within 4Å: Chain C: F.20, G.21, F.24, N.25 1 PLIP interactions: 1 interactions with chain C Hydrophobic interactions: C:F.20

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wu, N.C. et al., A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody. Plos Pathog. (2020)

Release Date

2020-10-28

Peptides

CR3022 heavy chain: A
CR3022 light chain: B
Spike glycoprotein: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
L

C
F

CR3022 heavy chain

CR3022 light chain

Spike glycoprotein

Related Entries With Identical Sequence